Frontiers in Oncology | Molecular and Cellular Oncology

Original Research

Published on 22 Jul 2024

Adipose microenvironment promotes hypersialylation of ovarian cancer cells

in Molecular and Cellular Oncology

Alexandra Fox
Garry D. Leonard
Nicholas Adzibolosu
Terrence Wong
Roslyn Tedja
Sapna Sharma
Radhika Gogoi
Robert Morris
Gil Mor
Charlie Fehl

Frontiers in Oncology

doi 10.3389/fonc.2024.1432333

4,895 views
4 citations

Original Research

Published on 12 Jul 2024

Unraveling the MicroRNA tapestry: exploring the molecular dynamics of locoregional recurrent rectal cancer

in Molecular and Cellular Oncology

N. Helge Meyer
Nika Kotnik
Gaetan Aime Noubissi Nzeteu
Léon C. van Kempen
Mirjam Mastik
Maximilian Bockhorn
Achim Troja

Frontiers in Oncology

doi 10.3389/fonc.2024.1407217

1,987 views
1 citation

Case Report

Published on 11 Jul 2024

Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab

in Molecular and Cellular Oncology

Yong Li
Jinpeng Huang
Xian Chen
Yongsong Ye
Xiaohua Du
Ioannis A. Voutsadakis
Mahesh Seetharam
Haibo Zhang
Min Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1416241

2,863 views

Correction

Published on 10 Jul 2024

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

in Molecular and Cellular Oncology

Yongrong Lei
Xishu Wang
Heng Sun
Yuna Fu
Yichen Tian
Ludi Yang
Jianhua Wang
Feng Xia

Frontiers in Oncology

doi 10.3389/fonc.2024.1438731

1,307 views

Mini Review

Published on 05 Jul 2024

The role of endothelial junctions in the regulation of the extravasation of tumor cells. A historical reappraisal

in Molecular and Cellular Oncology

Domenico Ribatti

Frontiers in Oncology

doi 10.3389/fonc.2024.1415601

1,857 views
1 citation

Review

Published on 04 Jul 2024

The functions and mechanisms of long non-coding RNA in colorectal cancer

in Molecular and Cellular Oncology

Yuning Lin
Wenzhen Zhao
Zhenyi Lv
Hongyan Xie
Ying Li
Zhongying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1419972

3,080 views
5 citations

Original Research

Published on 02 Jul 2024

Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

in Molecular and Cellular Oncology

Liujing Qu
Yu Xin
Jieni Feng
Xiaolei Ren
Zuming Li
Xueru Chen
Guangyan Miao
Jiankun Chen
Chengming Sun
Yue Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1389136

2,105 views
4 citations

Review

Published on 02 Jul 2024

Multiple aspects of matrix stiffness in cancer progression

in Molecular and Cellular Oncology

Alessandro Mancini
Maria Teresa Gentile
Francesca Pentimalli
Salvatore Cortellino
Michele Grieco
Antonio Giordano

Frontiers in Oncology

doi 10.3389/fonc.2024.1406644

8,934 views
29 citations

Original Research

Published on 01 Jul 2024

Architectural organization and molecular profiling of 3D cancer heterospheroids and their application in drug testing

in Molecular and Cellular Oncology

Boye Schnack Nielsen
Natasha Helleberg Madsen
Jesper Larsen
Isabella Skandorff
Monika Gad
Kim Holmstrøm

Frontiers in Oncology

doi 10.3389/fonc.2024.1386097

3,876 views
5 citations

Perspective

Published on 20 Jun 2024

Targeting RNA N6-methyladenosine modification—— a novel therapeutic target for HER2- positive gastric cancer

in Molecular and Cellular Oncology

Lijun Jia
Di Zhang
Xiaoman Zeng
Li Wu
Xiaowei Tian
Na Xing

Frontiers in Oncology

doi 10.3389/fonc.2024.1387444

1,776 views
2 citations

Retraction

Published on 18 Jun 2024

Retraction: The novel tumor suppressor gene ZNF24 induces THCA cells senescence by regulating Wnt signaling pathway resulting in inhibition of THCA tumorigenesis and invasion

in Molecular and Cellular Oncology

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2024.1443826

1,293 views

Original Research

Published on 13 Jun 2024

miR-617 interacts with the promoter of DDX27 and positively regulates its expression: implications for cancer therapeutics

in Molecular and Cellular Oncology

Neelanjana Sarkar
Radha Mishra
Champaka Gopal
Arun Kumar

Frontiers in Oncology

doi 10.3389/fonc.2024.1411539

2,662 views
11 citations

Mini Review

Published on 12 Jun 2024

Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma

in Molecular and Cellular Oncology

Rongzhong Wang
Shiyan Wang
Hua Jiang
Yingmei Lan
Shaobin Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1430684

2,527 views
2 citations

Review

Published on 10 Jun 2024

Exploring the role of m 6 A writer RBM15 in cancer: a systematic review

in Molecular and Cellular Oncology

Yuan Cao
Guanzhen Qiu
Yu Dong
Wei Zhao
Yong Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1375942

4,096 views
14 citations

Original Research

Published on 07 Jun 2024

Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genes

in Molecular and Cellular Oncology

Heather M. Sonnemann
Barbara Pazdrak
Barbara Nassif
Yimo Sun
Lama Elzohary
Amjad H. Talukder
Arjun S. Katailiha
Krishna Bhat
Gregory Lizée

Frontiers in Oncology

doi 10.3389/fonc.2024.1403052

3,161 views

Review

Published on 31 May 2024

MYCN in human development and diseases

in Molecular and Cellular Oncology

Yosuke Nishio
Kohji Kato
Hisashi Oishi
Yoshiyuki Takahashi
Shinji Saitoh

Frontiers in Oncology

doi 10.3389/fonc.2024.1417607

4,277 views
5 citations

Original Research

Published on 28 May 2024

Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-β1-NF-κB-MMP9 axis

in Molecular and Cellular Oncology

Fan Jiang
Youyi Chen
Nahoko Tomonobu
Rie Kinoshita
Ni Luh Gede Yoni Komalasari
Carlos Ichiro Kasano-Camones
Kazumi Ninomiya
Hitoshi Murata
Ken-ichi Yamamoto
Yuma Gohara

Frontiers in Oncology

doi 10.3389/fonc.2024.1371307

3,519 views
2 citations

Mini Review

Published on 23 May 2024

P53/NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells

in Molecular and Cellular Oncology

Fazeleh Ranjbar-Niavol
Niloufar Rezaei
Ying Zhao
Hamed Mirzaei
Moustapha Hassan
Massoud Vosough

Frontiers in Oncology

doi 10.3389/fonc.2024.1377761

3,014 views
5 citations

Original Research

Published on 23 May 2024

The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression

in Molecular and Cellular Oncology

Silvia Galbiati
Arianna Bettiga
Giorgia Colciago
Chiara Senti
Francesco Trevisani
Giulia Villa
Ilaria Marzinotto
Michele Ghidini
Rodolfo Passalacqua
Francesco Montorsi

Frontiers in Oncology

doi 10.3389/fonc.2024.1325157

2,265 views
7 citations

Original Research

Published on 22 May 2024

Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients

in Molecular and Cellular Oncology

Changye Zou
Renxuan Huang
Tiao Lin
Yaxian Wang
Jian Tu
Liwen Zhang
Bo Wang
Jintao Huang
Zhiqiang Zhao
Xianbiao Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1382276

4,089 views
6 citations

Review

Published on 21 May 2024

Organoids as a new approach for improving pediatric cancer research

in Molecular and Cellular Oncology

Silvia Lampis
Angela Galardi
Virginia Di Paolo
Angela Di Giannatale

Frontiers in Oncology

doi 10.3389/fonc.2024.1414311

4,703 views
5 citations

Review

Published on 21 May 2024

Biological functions and therapeutic potential of SRY related high mobility group box 5 in human cancer

in Molecular and Cellular Oncology

Juan-di Xue
Wan-fang Xiang
Ming-qin Cai
Xiao-yun Lv

Frontiers in Oncology

doi 10.3389/fonc.2024.1332148

2,310 views
3 citations

Editorial

Published on 20 May 2024

Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge

in Molecular and Cellular Oncology

Eleonora Lai
Pina Ziranu
Francesco Pezzella
Andrea Pretta
Nicole Liscia
Zhiwei Hu

Frontiers in Oncology

doi 10.3389/fonc.2024.1428174

1,082 views

Review

Published on 17 May 2024

MicroRNAs and angiosarcoma: are there promising reports?

in Molecular and Cellular Oncology

Amir Modarresi Chahardehi
Arya Afrooghe
Nikoo Emtiazi
Sajjad Rafiei
Negin Jafarkhanloo Rezaei
Sarvin Dahmardeh
Fatemeh Farz
Zahra Naderi
Reza Arefnezhad
Hossein Motedayyen

Frontiers in Oncology

doi 10.3389/fonc.2024.1385632

3,470 views
4 citations

3,128 articles

articles

Adipose microenvironment promotes hypersialylation of ovarian cancer cells

Unraveling the MicroRNA tapestry: exploring the molecular dynamics of locoregional recurrent rectal cancer

Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

The role of endothelial junctions in the regulation of the extravasation of tumor cells. A historical reappraisal

The functions and mechanisms of long non-coding RNA in colorectal cancer

Downregulation of PRKCI inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway

Multiple aspects of matrix stiffness in cancer progression

Architectural organization and molecular profiling of 3D cancer heterospheroids and their application in drug testing

Targeting RNA N6-methyladenosine modification—— a novel therapeutic target for HER2- positive gastric cancer

Retraction: The novel tumor suppressor gene ZNF24 induces THCA cells senescence by regulating Wnt signaling pathway resulting in inhibition of THCA tumorigenesis and invasion

miR-617 interacts with the promoter of DDX27 and positively regulates its expression: implications for cancer therapeutics

Prospects for the clinical application of exosomal circular RNA in squamous cell carcinoma

Exploring the role of m 6 A writer RBM15 in cancer: a systematic review

Placental co-transcriptional activator Vestigial-like 1 (VGLL1) drives tumorigenesis via increasing transcription of proliferation and invasion genes

MYCN in human development and diseases

Dissection of the signal transduction machinery responsible for the lysyl oxidase-like 4-mediated increase in invasive motility in triple-negative breast cancer cells: mechanistic insight into the integrin-β1-NF-κB-MMP9 axis

P53/NANOG balance; the leading switch between poorly to well differentiated status in liver cancer cells

The long noncoding RNA SUMO1P3 as urinary biomarker for monitoring bladder cancer progression

Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients

Organoids as a new approach for improving pediatric cancer research

Biological functions and therapeutic potential of SRY related high mobility group box 5 in human cancer

Editorial: Angiogenesis and access to vasculature as a target in gastrointestinal tumors and predictive biomarkers identification: an open challenge

MicroRNAs and angiosarcoma: are there promising reports?